Assessment of Quality of Life in IPF Patients: a Multicenter Observational Study

Overview

Journal Sarcoidosis Vasc Diffuse Lung Dis

Specialties Allergy & Immunology
Cardiology & Vascular Diseases
Pulmonary Medicine

Date 2024 Sep 24

PMID 39315976

Authors

Fatih Uzer

Aykut Cilli

Ismail Hanta

Funda Coskun

Can Sevinc

Ahmet Ursavas

Asim Leblebici

Gozde Yilmaz

Gamze Yazici Celik

Ibrahim Kamel

Affiliations

Soon will be listed here.

Abstract

Aim: This study aimed to examine how dyspnea, cough, sleep disruption, anxiety, depression, and physiological factors affect the quality of life in newly diagnosed, untreated IPF patients.

Methods: This study is a multicenter observational study. Patients not receiving antifibrotic treatment were included. To assess patients' quality of life, Leicester Cough Questionnaire (LCQ), St. George's Respiratory Questionnaire (SGRQ), Short Form-36 (SF-36), Hospital Anxiety and Depression Scale (HADS), Borg Dyspnea Index (BDI), Modified Medical Research Council Dyspnea Scale (MMRC) score, Composite Physiological Index (CPI), Gender Age and physiology (GAP) score, and Pittsburgh Sleep Quality Index (PSQI) were administered.

Results: Among 88 patients (mean age: 67.6±8.5 years), 81.9% were diagnosed with IPF through HRCT, 14.8% through surgery, and 3.4% via cryobiopsy. The average disease duration was 2.2±2.9 years. Over 50% experienced moderate to severe depression, and 40% had moderate to severe anxiety. In the IPF group, 13.6% had possible usual interstitial pneumonia (UIP), and 81.8% had definite UIP pattern. No significant differences were found between UIP groups in various scores. Anxiety and depression correlated negatively with respiratory function and positively with MMRC score and BDI. Sleep quality scores had similar correlations. Patients with good sleep quality had better respiratory parameters (p=0.013), lower MMRC (p=0.004), BDI (p=0.026), and CPI (p=0.047). -Conclusion: A notable number of IPF patients in follow-up show symptoms of anxiety and depression. Moreover, declining respiratory function not only diminishes sleep quality but also elevates dyspnea scores.

References

Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D . Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med. 2005; 16(2):105-112. DOI: 10.1016/j.ejim.2004.09.013. View

Yount S, Beaumont J, Chen S, Kaiser K, Wortman K, Van Brunt D . Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis. Lung. 2016; 194(2):227-34. DOI: 10.1007/s00408-016-9850-y. View

Buysse D, Reynolds 3rd C, Monk T, BERMAN S, Kupfer D . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2):193-213. DOI: 10.1016/0165-1781(89)90047-4. View

Yorke J, Spencer L, Duck A, Ratcliffe S, Kwong G, Longshaw M . Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA). BMJ Open Respir Res. 2014; 1(1):e000024. PMC: 4212790. DOI: 10.1136/bmjresp-2014-000024. View

Chang J, Curtis J, Patrick D, Raghu G . Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999; 116(5):1175-82. DOI: 10.1378/chest.116.5.1175. View

Patel A, Siegert R, Brignall K, Gordon P, Steer S, Desai S . The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012; 67(9):804-10. DOI: 10.1136/thoraxjnl-2012-201581. View

Prior T, Hoyer N, Shaker S, Davidsen J, Yorke J, Hilberg O . Validation of the IPF-specific version of St. George's Respiratory Questionnaire. Respir Res. 2019; 20(1):199. PMC: 6714302. DOI: 10.1186/s12931-019-1169-9. View

Yorke J, Jones P, Swigris J . Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax. 2010; 65(10):921-6. PMC: 3697105. DOI: 10.1136/thx.2010.139121. View

Raghu G, Remy-Jardin M, Myers J, Richeldi L, Ryerson C, Lederer D . Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5):e44-e68. DOI: 10.1164/rccm.201807-1255ST. View

10.

Belkin A, Swigris J . Health-related quality of life in idiopathic pulmonary fibrosis: where are we now?. Curr Opin Pulm Med. 2013; 19(5):474-9. DOI: 10.1097/MCP.0b013e328363f479. View

11.

Lindell K, Olshansky E, Song M, Zullo T, Gibson K, Kaminski N . Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung. 2010; 39(4):304-13. PMC: 3467095. DOI: 10.1016/j.hrtlng.2009.08.005. View

12.

Wells A, Desai S, Rubens M, Goh N, Cramer D, Nicholson A . Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003; 167(7):962-9. DOI: 10.1164/rccm.2111053. View

13.

Martinez F, de Oca M, Whyte R, Stetz J, Gay S, Celli B . Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med. 1997; 155(6):1984-90. DOI: 10.1164/ajrccm.155.6.9196106. View

14.

Janssens J, Breitenstein E, Rochat T, Fitting J . Does the 'oxygen cost diagram' reflect changes in six minute walking distance in follow up studies?. Respir Med. 1999; 93(11):810-5. DOI: 10.1016/s0954-6111(99)90266-4. View

15.

de Vries J, Kessels B, Drent M . Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J. 2001; 17(5):954-61. DOI: 10.1183/09031936.01.17509540. View

16.

Mura M, Porretta M, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N . Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J. 2012; 40(1):101-9. DOI: 10.1183/09031936.00106011. View

17.

Lechtzin N, Hilliard M, Horton M . Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest. 2013; 143(6):1745-1749. PMC: 4694113. DOI: 10.1378/chest.12-2870. View